$MTNB News Article - Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammatory Disease Models with Oral LNC-Delivered Small Oligonucleotides https://marketwirenews.com/news-releases/mati...97680.html
(0)
(0)
Matinas BioPharma Holdings (MTNB) Stock Research Links